Australia’s complementary medicines industry is a thriving and strategically important part of the nation’s healthcare, manufacturing and economy.
The Australian complementary medicines industry generates approximately $6.3 billion in annual revenue and directly employs nearly 16,000 people. With 82 TGA-licensed manufacturing facilities across Australia and annual exports reaching $1.2 billion, the sector represents an Australian manufacturing and export success story.
Complementary medicines are also a core part of everyday health for Australians. Almost three-quarters of Australians (74%) reported using supplements in the past year, with 41% taking them daily.
Australia’s complementary medicines are recognised internationally for their quality, safety and efficacy. Our strong regulatory and manufacturing standards have helped establish significant global demand for Australian-made complementary medicines, particularly in key export markets across Asia.
Forecast value of Australia’s complementary medicines industry in 2025.
Projected value of the Australian complementary medicines industry by 2030.
Of Australians reported using supplements in the past year.
Of Australians take supplements daily.
People directly employed by Australia’s complementary medicines industry.
TGA-licensed complementary medicine manufacturing facilities across Australia.
Annual Australian complementary medicines exports.
Complementary medicines encompass a wide range of products, from vitamin and dietary supplements (VDS) to herbal remedies and traditional medicines like Ayurveda and Chinese medicine. These products are designed to complement conventional medical treatments, offering a holistic approach to health and wellbeing.
Complementary medicines, including traditional and integrative therapies, are recognised globally, including by the World Health Organisation.
Australia’s complementary medicines sector was forecast to reach $6.3 billion in 2025, up from $4.6 billion in 2021, and is projected to reach more than $7.4 billion by 2030.
Industry growth of around 3–4% annually is expected between 2025 and 2030, driven by sustained demand for preventive health, product innovation and trusted complementary medicines.
Almost three-quarters of Australians (74%) reported using supplements in the past year, with 41% taking them daily. Women are more likely to use supplements than men, with reported usage of 78% and 69% respectively.
Australians are increasingly using complementary medicines as part of a proactive approach to staying well.
Around 58% of Australians use supplements mainly for prevention, compared with 24% who use them primarily to manage a diagnosed condition. Almost two-thirds (64%) report using supplements proactively.
Australia has maintained a strong domestic complementary medicines manufacturing sector, with 82 TGA-licensed manufacturing facilities across the country.
Australian complementary medicines operate within a rigorous regulatory framework administered by the Therapeutic Goods Administration (TGA), helping underpin confidence in the safety and quality of locally available products.
Australia’s manufacturing standards are also central to the industry’s international reputation. Australian complementary medicines are recognised around the world for their quality, safety and efficacy, and “Made in Australia” continues to carry premium value in major international markets.
Australia’s complementary medicines industry is a significant manufacturing and export success story, with annual exports reaching $1.02 billion.
Strong international demand is underpinned by Australia’s reputation for high-quality manufacturing, rigorous standards and trusted products.
China (including Hong Kong) continues to dominate as the largest export destination. Vietnam has rapidly emerged as Australia’s second-largest export destination. Other important and emerging markets include New Zealand, South Korea, Thailand, India, Malaysia, Indonesia, Singapore and the United Arab Emirates.
The Complementary Medicines Australia 2025 Industry Snapshot provides data and analysis on the size, growth and economic contribution of Australia’s complementary medicines industry, Australian consumer trends, natural therapies, manufacturing, exports and international market opportunities.
Complementary Medicines Australia (CMA) is the peak industry body for the $6.3 billion complementary medicines sector in Australia, representing businesses throughout the supply chain. Complementary medicines encompass vitamin and mineral supplements, targeted nutritional and herbal therapeutics based on modern scientific trials, as well as traditional medicines that are based on generations of cultural use across the globe. Complementary and traditional medicines are recognised as fundamentally important to integrate into health systems worldwide by the World Health Organization.
CMA collaborates with the Therapeutic Goods Administration (TGA) and other government agencies to develop and uphold effective, balanced regulatory standards for these products. CMA advocates for improved consumer access to high-quality complementary medicines and seeks opportunities to foster innovation, industry growth and Australia’s competitive advantage in global markets.
